Cite
Esposito S, Abu-Raya B, Bonanni P, et al. Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper. Front Immunol. 2021;12:708939doi: 10.3389/fimmu.2021.708939.
Esposito, S., Abu-Raya, B., Bonanni, P., Cahn-Sellem, F., Flanagan, K. L., Martinon Torres, F., Mejias, A., Nadel, S., Safadi, M. A. P., & Simon, A. (2021). Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper. Frontiers in immunology, 12708939. https://doi.org/10.3389/fimmu.2021.708939
Esposito, Susanna, et al. "Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper." Frontiers in immunology vol. 12 (2021): 708939. doi: https://doi.org/10.3389/fimmu.2021.708939
Esposito S, Abu-Raya B, Bonanni P, Cahn-Sellem F, Flanagan KL, Martinon Torres F, Mejias A, Nadel S, Safadi MAP, Simon A. Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper. Front Immunol. 2021 Aug 11;12:708939. doi: 10.3389/fimmu.2021.708939. eCollection 2021. PMID: 34456918; PMCID: PMC8386277.
Copy
Download .nbib
